Evidence map›Paper›PMID 32359353›Full record

ArticleBMC neurology2020

Low grade albuminuria as a risk factor for subtypes of stroke - the HUNT Study in Norway.

Jens W Horn, Solfrid Romundstad, Hanne Ellekjær, Imre Janszky, Julie Horn

Open access · goldAbstract read
In one paragraph

Article in BMC neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Jens W HornDepartment of Internal Medicine, Levanger Hospital Kirkegata 2, Health Trust Nord-Trøndelag, N-7600, Levanger, Norway. Jens.Horn@ntnu.no.ORCID http://orcid.org/0000-0003-1220-9998
Solfrid RomundstadDepartment of Internal Medicine, Levanger Hospital Kirkegata 2, Health Trust Nord-Trøndelag, N-7600, Levanger, Norway.
Hanne EllekjærStroke Unit, Department of Internal Medicine, St. Olav's Hospital, Trondheim, Norway.
Imre JanszkyDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Julie HornDepartment of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Norwegian University of Science and Technology · NOSemmelweis University · HU

Funding

Liaison Committee for education, research, and innovation in Central Norway 17/38297Liaison Committee for education, research, and innovation in Central Norway 2016/29014
6 · The paper itself

Abstract

background and purposeAlbuminuria is a marker for endothelial dysfunction and knowledge on its association with stroke and stroke subtypes are limited.

methodsCorresponding data from 7261 participants of the population-based HUNT2 study (1995-1997) was linked with hospital records, identified all patients registered and diagnosed with a first-time stroke. Each diagnosis was validated by reviewal of the medical record appertaining to the individual. We then applied Cox proportional hazard models to estimate the hazard ratios (HRs) for the association between albuminuria (measured as albumin-to-creatinine-ratio, ACR) and diagnosis of stroke and stroke subtypes.

results703 (9.7%) participants developed a first ischemic stroke during a median follow-up of 15 years. Higher albuminuria was associated with a higher rate for ischemic stroke and the risk rose steadily with increasing ACR (15% increment per unit increase in ACR concentration in mg/mmol). In the fully adjusted model, the HR for all ischemic strokes was 1.56 (95% CI 1.24-1.95) for those with an ACR ≥3 mg/mmol compared to participants with an ACR < 1 mg/mmol. Overall, increasing ACR was associated with a higher risk of all ischemic stroke subtypes. This was seen to be strongest for lacunar stroke (HR 1.75, CI 1.12-2.72, p = 0.019), and also for stroke of undetermined etiology (HR 1.53, CI 1.11-2.11, p = 0.009) and those caused by atherosclerosis in the large arteries (HR 1.51, CI 0.78-2.94, p = 0.186) than for cardio-embolic stroke (HR 1.22, CI 0.64-2.3, p = 0.518).

conclusionsAlbuminuria is an important risk factor, potentially already at low grade, for ischemic stroke especially for lacunar subtype. Measuring albuminuria is both cheap and readily available. This offers the opportunity to evaluate the risk for endothelial dysfunction and thus the subsequent risk for stroke and cerebral small vessel disease.

Indexed as

AlbuminuriaStrokeCohort StudiesHumansNorwayRisk FactorsAlbuminuriaCerebral small vessel diseaseStroke

Identifiers

PMID32359353
PMCPMC7196218
OpenAlexW3021956429

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.